updated 11/2/2006 12:54:58 PM ET 2006-11-02T17:54:58

A meningitis vaccine shortage is over, and federal health officials are again recommending the shot for preteens as well as college and high school students.

  1. Don't miss these Health stories
    1. Splash News
      More women opting for preventive mastectomy - but should they be?

      Rates of women who are opting for preventive mastectomies, such as Angeline Jolie, have increased by an estimated 50 percent in recent years, experts say. But many doctors are puzzled because the operation doesn't carry a 100 percent guarantee, it's major surgery -- and women have other options, from a once-a-day pill to careful monitoring.

    2. Larry Page's damaged vocal cords: Treatment comes with trade-offs
    3. Report questioning salt guidelines riles heart experts
    4. CDC: 2012 was deadliest year for West Nile in US
    5. What stresses moms most? Themselves, survey says

The government approved the new vaccine for marketing last year, and the U.S. Centers for Disease Control and Prevention recommended it for three age groups — college freshmen, teens entering high school and children aged 11-12.

But in May, when demand appeared to be exceeding supply, the government took preteens off the priority list. College freshmen living in dorms where the infection can more easily spread were considered at higher risk.

Now that the summer back-to-school demand has eased, so have order restrictions and shipment delays, said a spokeswoman for Sanofi Pasteur, which manufactures the Menactra vaccine. The company said it is producing 6 million doses this year, and next year will exceed 7 million.

Doctors who deferred 11- and 12-year-olds in the spring and summer can now call the kids back in for the shots, CDC officials said Thursday.

© 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Discuss:

Discussion comments

,

Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments